Positron emission tomography (PET) using the second-generation translocator protein (TSPO) ligand [18F] DPA-714 can directly assess microglial activation in vivo, offering a robust and effective means of monitoring neuroinflammatory activity within the CNS in a sensitive manner in the context of neurological disease [11,12]. Here, TSPO is linked to nervous system disorder.